|
Dr. Barber has over 25 years experience in the biomedical industry including 16 years in biopharmaceutical research and development. Prior to joining CytRx, Dr. Barber spent nine years at Immusol, a biopharmaceutical company based in San Diego , California . He served as the company's Chief Technical Officer and Vice President of Research and Development, where he invented the company's mRNA inactivation technology for drug target discovery and validation, and led a multifunctional department of over 70 people. Dr. Barber also played a major role in growing the company from a capitalization of $6 million in 1994 to $305 million in 2003. Before working at Immusol, Dr. Barber spent seven years in various management positions at Viagene, which was acquired by Chiron. At Viagene, Dr. Barber most recently served as Associate Director of Oncology, researching and developing gene therapy vaccines for the treatment of HIV and various cancers. Dr. Barber received both his B.S. and Ph.D. in Biochemistry from the University of California, Los Angeles. He also carried out his post-doctoral fellowship at the Salk Institute for Biological Studies in La Jolla, California. | 